Atomistry » Fluorine » PDB 8w9b-8x2a » 8wxy
Atomistry »
  Fluorine »
    PDB 8w9b-8x2a »
      8wxy »

Fluorine in PDB 8wxy: Crystal Structure of the First Bromodomain of Human BRD4 in Complex with the Inhibitor 23

Protein crystallography data

The structure of Crystal Structure of the First Bromodomain of Human BRD4 in Complex with the Inhibitor 23, PDB code: 8wxy was solved by H.Xu, X.Zhao, H.Shen, Y.Xu, X.Wu, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 121.52 / 2.87
Space group P 61 2 2
Cell size a, b, c (Å), α, β, γ (°) 140.323, 140.323, 135.226, 90, 90, 120
R / Rfree (%) 18.8 / 24.9

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of the First Bromodomain of Human BRD4 in Complex with the Inhibitor 23 (pdb code 8wxy). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the Crystal Structure of the First Bromodomain of Human BRD4 in Complex with the Inhibitor 23, PDB code: 8wxy:
Jump to Fluorine binding site number: 1; 2; 3;

Fluorine binding site 1 out of 3 in 8wxy

Go back to Fluorine Binding Sites List in 8wxy
Fluorine binding site 1 out of 3 in the Crystal Structure of the First Bromodomain of Human BRD4 in Complex with the Inhibitor 23


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of the First Bromodomain of Human BRD4 in Complex with the Inhibitor 23 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F201

b:72.7
occ:1.00
FAT A:XGN201 0.0 72.7 1.0
CAO A:XGN201 1.3 59.5 1.0
CAP A:XGN201 2.3 55.7 1.0
CAN A:XGN201 2.3 58.6 1.0
FAT B:XGN201 2.8 81.5 1.0
CAN B:XGN201 3.4 67.2 1.0
CAO B:XGN201 3.5 69.3 1.0
CAQ A:XGN201 3.5 56.7 1.0
CAM A:XGN201 3.6 54.3 1.0
CAL A:XGN201 4.0 54.2 1.0
OD2 B:ASP145 4.0 100.8 1.0
CAM B:XGN201 4.6 62.7 1.0
CAS A:XGN201 4.6 60.0 1.0
OD2 A:ASP145 4.6 100.3 1.0
CZ2 B:TRP81 4.7 48.7 1.0
CAR A:XGN201 4.7 53.7 1.0
CAP B:XGN201 4.8 62.9 1.0
CG B:ASP145 4.9 111.8 1.0

Fluorine binding site 2 out of 3 in 8wxy

Go back to Fluorine Binding Sites List in 8wxy
Fluorine binding site 2 out of 3 in the Crystal Structure of the First Bromodomain of Human BRD4 in Complex with the Inhibitor 23


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Crystal Structure of the First Bromodomain of Human BRD4 in Complex with the Inhibitor 23 within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F201

b:81.5
occ:1.00
FAT B:XGN201 0.0 81.5 1.0
CAO B:XGN201 1.4 69.3 1.0
CAN B:XGN201 2.4 67.2 1.0
CAP B:XGN201 2.4 62.9 1.0
FAT A:XGN201 2.8 72.7 1.0
CAN A:XGN201 3.2 58.6 1.0
CAO A:XGN201 3.4 59.5 1.0
CAM B:XGN201 3.7 62.7 1.0
CAQ B:XGN201 3.7 59.3 1.0
OD2 B:ASP145 3.8 100.8 1.0
OD2 A:ASP145 4.0 100.3 1.0
CAL B:XGN201 4.2 61.7 1.0
CAM A:XGN201 4.5 54.3 1.0
CAP A:XGN201 4.7 55.7 1.0
CAR B:XGN201 4.8 63.6 1.0
CAS B:XGN201 4.8 58.3 1.0
CG B:ASP145 4.9 111.8 1.0
CG A:ASP145 5.0 98.2 1.0
CAR A:XGN201 5.0 53.7 1.0

Fluorine binding site 3 out of 3 in 8wxy

Go back to Fluorine Binding Sites List in 8wxy
Fluorine binding site 3 out of 3 in the Crystal Structure of the First Bromodomain of Human BRD4 in Complex with the Inhibitor 23


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Crystal Structure of the First Bromodomain of Human BRD4 in Complex with the Inhibitor 23 within 5.0Å range:
probe atom residue distance (Å) B Occ
C:F201

b:112.2
occ:1.00
FAT C:XGN201 0.0 112.2 1.0
CAO C:XGN201 1.3 95.0 1.0
CAN C:XGN201 2.3 92.4 1.0
CAP C:XGN201 2.4 85.4 1.0
CAM C:XGN201 3.6 88.0 1.0
CAQ C:XGN201 3.6 91.6 1.0
OD2 C:ASP145 3.9 113.7 1.0
CAL C:XGN201 4.1 87.8 1.0
CB C:ASP145 4.7 117.5 1.0
CAR C:XGN201 4.7 85.9 1.0
CG C:ASP145 4.8 116.4 1.0
CAS C:XGN201 4.8 99.4 1.0

Reference:

W.Jiang, Q.Hou, H.Xu, K.Yang, X.Wang, K.Zhang, Y.Zeng, W.Li, B.Wang, G.Luo, X.Zhao, H.Shen, Y.Xu, X.Wu. Discovery of Novel Phenoxyaryl Pyridones As Bromodomain and Extra-Terminal Domain (Bet) Inhibitors with High Selectivity For the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia. J.Med.Chem. 2024.
ISSN: ISSN 0022-2623
PubMed: 38175809
DOI: 10.1021/ACS.JMEDCHEM.3C02104
Page generated: Wed Jul 16 10:06:30 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy